Boc-D-Lys(Fmoc)-OH is a protected derivative of the amino acid lysine, bearing both an Nα-Boc (tert-butoxycarbonyl) protecting group and an ε-side-chain Fmoc (9H-fluoren-9-ylmethoxycarbonyl) protecting group. The molecule contains a free carboxyl group and a stereochemically defined D-configuration at the lysine α-carbon, while the ε-amino functionality is masked as an Fmoc carbamate to control chemoselectivity during stepwise assembly. In peptide chemistry and solid-phase peptide synthesis workflows, this orthogonally protected lysine analogue is used as a precursor that enables sequential deprotection and coupling to introduce lysine-derived side-chain functionality in controlled protected form.
CAT No: CP25181
CAS No:115186-31-7
Synonyms/Alias:Boc-D-Lys(Fmoc)-OH;115186-31-7;D-Lysine, N2-[(1,1-dimethylethoxy)carbonyl]-N6-[(9H-fluoren-9-ylmethoxy)carbonyl]-;MFCD00076966;(2R)-6-(9H-fluoren-9-ylmethoxycarbonylamino)-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid;Nalpha-Boc-Nepsilon-Fmoc-D-lysine;N-alpha-t-Butyloxycarbonyl-N-epsilon-(9-fluorenylmethyloxycarbonyl)-D-lysine;Boc-N-Epsilon-Fmoc-D-Lysine;N2-Boc-N6-Fmoc-D-lysine;SCHEMBL12040103;DTXSID50554381;JYEVQYFWINBXJU-JOCHJYFZSA-N;AKOS015836453;AKOS015895478;AC-8626;CS-W016745;FB33820;AC-19278;AS-12894;F10560;EN300-7376887;N6-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N2-(tert-butoxycarbonyl)-D-lysine;(R)-6-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-(tert-butoxycarbonylamino)hexanoic acid;N~2~-(tert-Butoxycarbonyl)-N~6~-{[(9H-fluoren-9-yl)methoxy]carbonyl}-D-lysine;(2R)-2-[(TERT-BUTOXYCARBONYL)AMINO]-6-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}HEXANOIC ACID;(2R)-2-{[(tert-butoxy)carbonyl]amino}-6-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid;(R)-6-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)hexanoic acid;
Chemical Name:N-alpha-t-Butyloxycarbonyl-N-epsilon-(9-Fluorenylmethyloxycarbonyl)-D-lysine
Boc-D-Lys(Fmoc)-OH is a protected lysine building block featuring the D-configuration at the amino acid stereocenter and orthogonal protection suitable for stepwise peptide assembly. The molecule carries an N-Boc group for temporary amine protection alongside an Fmoc-protected side-chain amino functionality, enabling controlled functional-group availability during segment coupling and subsequent deprotection steps. This reagent is widely used in peptide synthesis workflows where stereochemical control and selective exposure of amine sites are required to generate D-lysine-containing sequences or lysine-derived motifs.
1. Stereocontrolled Peptide Synthesis
Boc-D-Lys(Fmoc)-OH is used by peptide synthesis teams to incorporate D-lysine residues into peptides and peptide-like scaffolds with explicit stereochemical control. The protected lysine framework supports downstream coupling strategies while maintaining the integrity of both the backbone and side-chain amine functionalities until the appropriate deprotection stage. Researchers developing D-amino-acid enriched peptides for structure-function studies, protease-stability investigations, or conformational tuning often select this type of orthogonally protected lysine derivative to manage chemoselectivity during assembly.
2. Orthogonal Side-Chain Amine Handling
Boc-D-Lys(Fmoc)-OH is commonly selected in workflows that require controlled access to the lysine side-chain amine for later derivatization. The presence of an Fmoc-protected side-chain amino group allows synthesis to proceed without premature side-chain reactivity, while the Boc protection provides an additional level of protection for the terminal amine during earlier steps. This protection pattern is particularly useful for preparing lysine-bearing intermediates that will be functionalized after key coupling events, such as when constructing branched peptides, installing side-chain modifications, or preparing defined lysine substitution patterns for chemical biology studies.
3. Segment Coupling And Library Production
Boc-D-Lys(Fmoc)-OH supports segment condensation and modular peptide construction where protected amino acid units are assembled into larger sequences under controlled deprotection schedules. Custom peptide manufacturers and academic peptide chemistry groups use this reagent when building peptide libraries that include D-lysine variants, because the orthogonal protection strategy helps standardize intermediate handling across multiple analogs. By enabling predictable exposure of reactive amine sites at designated steps, the reagent fits well into parallel synthesis workflows that require consistent functional-group management from early coupling through final purification.
4. Lysine-Derived Intermediate Development
Boc-D-Lys(Fmoc)-OH is also used to generate protected lysine-containing intermediates for subsequent synthetic elaboration beyond straightforward peptide assembly. Teams developing modified peptide fragments, lysine-based linkers, or amine-functionalized building blocks rely on the reagent's dual protection to keep both amine sites masked during intermediate preparation, then selectively unmask the required functionality for downstream coupling or derivatization. This makes it a practical choice for chemical synthesis programs that need defined amine reactivity timing while maintaining stereochemical fidelity of the D-lysine center.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.